Design and synthesis of various 1,3,4-oxadiazoles as AChE and LOX enzyme inhibitors

N-Substituted-2-propanamide analogues of 1,3,4-oxadiazole have been synthesized using a multi-step synthetic protocol to explore new therapeutic anti-enzymatic agents. Herein, we have merged sulfonyl, piperidine, oxadiazole and amide into a single unit to synthesize a library of unique compounds, 8a...

Full description

Saved in:
Bibliographic Details
Published inHeterocyclic Communications Vol. 29; no. 1; pp. 149 - 60
Main Authors Iqbal Javed, Mallhi Ali Imran, ur Rehman Aziz, Al-Mijalli Samiah H., un-Nisa Mehr, Zafar Fatiqa, Shahzad Sohail, Rasool Shahid, Iqbal Munawar, Shah Syed Adnan Ali
Format Journal Article
LanguageEnglish
Published Berlin Walter de Gruyter GmbH 15.11.2023
De Gruyter
Subjects
1,3,4-oxadiazole
acetyl cholinesterase
Chemical synthesis
Enzymes
In vivo methods and tests
Infrared spectroscopy
lipoxygenase
Liquid oxygen
Molecular docking
Molecular structure
NMR
Nuclear magnetic resonance
Oxadiazoles
Pharmacology
Physostigmine
Piperidine
Spectrum analysis
urease
Online AccessGet full text

Cover

More Information
Summary:N-Substituted-2-propanamide analogues of 1,3,4-oxadiazole have been synthesized using a multi-step synthetic protocol to explore new therapeutic anti-enzymatic agents. Herein, we have merged sulfonyl, piperidine, oxadiazole and amide into a single unit to synthesize a library of unique compounds, 8a–n. The molecular structures of all synthesized compounds were verified by 13C-NMR, 1H-NMR, HRMS and IR spectroscopy. Furthermore, the compounds were screened for their inhibition potential against acetylcholinesterase (AChE), urease and lipoxygenase (LOX) enzymes. A considerable inhibition potential was observed for three compounds against LOX with quercetin as a reference standard, two compounds against urease with thiourea as a reference standard and two compounds against AChE with eserine as a reference standard. Through molecular docking investigations, we were able to correlate the overall impact and inhibition criteria by the structure–activity relationship via the interactions between synthesized compounds and active sites of enzymes. Pharmacodynamics, pharmacokinetics and in vivo studies may be investigated further for the most active compounds to substantiate them as potential anti-enzymatic medications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0793-0283
2191-0197
DOI:10.1515/hc-2022-0169